Maintenance treatment for schizophrenia with quetiapine

Human Psychopharmacology

Volumn 19, Issue 2, 2004, Pages 121-124

  Buckley, Peter F ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Atypical antipsychotics; Maintenance; Quetiapine; Schizophrenia

Indexed keywords

HALOPERIDOL; QUETIAPINE;

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG RESPONSE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL ANALYSIS;

BRIEF PSYCHIATRIC RATING SCALE; CONFIDENCE INTERVALS; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA;

EID: 1542516233     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.573     Document Type: Article

References (21)

1. American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. American Psychiatric Association: Washington, DC.
2. Arato M, O'Connor R, Meltzer HY. 2002. A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study. Int Clin Psychopharmacol 17: 207-215.
3. Arvanitis LA, Miller BG, Seroquel Trial 13 Study Group. 1997. Multiple fixed doses of 'Seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 42: 233-246.
4. Arvanitis LA, Rak IW. 1997. The long-term efficacy and safety of 'Seroquel' (quetiapine). Schizophr Res 24: 196-197.
5. Borison RL, Arvanitis LA, Miller BG, the US Seroquel Study Group. 1996. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. J Clin Psychopharmacol 16: 158-169.
6. Brecher M, Rak IW, Melvin K, Jones AM. 2000. The long-term effect of quetiapine (Seroquel) monotherapy on weight in patients with schizophrenia. Int J Psych Clin Pract 4: 287-291.
7. Copolov DL, Link CG, Kowalcyk B. 2000. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia. Psychol Med 30: 95-105.
8. Csernansky JG, Mahmoud R, Brenner R. 2002. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 346: 16-22.
9. Davis JM, Chen N, Glick ID. 2003. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60: 553-564.
10. Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S. 2000. Olanzapine for schizophrenia. Cochrane Database Syst Rev (2): CD001359.
11. Emsley R, Oosthuizen P. 2003. The new and evolving pharmacotherapy of schizophrenia. Psych Clin N Am 26: 141-164.
12. Geddes J, Freemantle N, Harrison P, Bebbington P. 2000. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br Med J 321: 1371-1376.
13. Hirsch SR, Kissling W, Bäuml J, Power A, O'Connor R. 2002. A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia. J Clin Psychiatry 63: 516-523.
14. King DJ, Link CG, Kowalcyk B. 1998. A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia. Psychopharmacology (Berl) 137: 139-146.
15. Kujawa M, Sahn AR, Ingenito GG, et al. 2002. Aripiprazole for long-term maintenance treatment of schizophrenia. Int J Neuropsychopharmacol 5: S186.
16. Leucht S, Barnes TR, Kissling W, Engel RR, Correll C, Kane JM. 2003. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry 160: 1209-1222.
17. Marder SR, Glynn SM, Wirshing WC, et al. 2003. Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes. Am J Psychiatry 160: 1405-1412.
18. Mullen J, Jibson MD, Sweitzer D for the Quest Study Group. 2001. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the Quetiapine Experience with Safety and Tolerability (QUEST) study. Clin Ther 23: 1839-1854.
19. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. 1997. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry 54: 549-557.
20. Tran PV, Hamilton SH, Kuntz AJ, et al. 1997. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 17: 407-418.
21. Tran PV, Tollefson OD, Sanger TM, Lu Y, Berg PH, Beasley CM Jr. 1999. Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapy. Br J Psychiatry 174: 15-22.